[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Khoo et al., 2017 - Google Patents

Advancing techniques and insights in circulating tumor cell (ctc) research

Khoo et al., 2017

View PDF
Document ID
2440554220028636564
Author
Khoo B
Chaudhuri P
Lim C
Warkiani M
Publication year
Publication venue
Ex Vivo Engineering of the Tumor Microenvironment

External Links

Snippet

Cancer is a major cause of mortality worldwide, with a disease burden estimated to grow over the coming decades. Circulating tumor cells (CTCs) are rare cancer cells released from the primary or metastatic tumors and transported though the peripheral circulatory system to …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/558—Immunoassay; Biospecific binding assay using diffusion or migration of antigen or antibody
    • G01N33/561—Immunoelectrophoresis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40—Concentrating samples
    • G01N1/4077—Concentrating samples by other techniques involving separation of suspended solids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material

Similar Documents

Publication Publication Date Title
Bankó et al. Technologies for circulating tumor cell separation from whole blood
Maly et al. Circulating tumor cells in diagnosis and treatment of lung cancer
Hao et al. Size-based separation methods of circulating tumor cells
Ferreira et al. Circulating tumor cell technologies
Ribeiro-Samy et al. Fast and efficient microfluidic cell filter for isolation of circulating tumor cells from unprocessed whole blood of colorectal cancer patients
Gabriel et al. Circulating tumor cells: a review of non–EpCAM-based approaches for cell enrichment and isolation
Harouaka et al. Circulating tumor cells: advances in isolation and analysis, and challenges for clinical applications
Zhang et al. Microfluidics and cancer: are we there yet?
Millner et al. Circulating tumor cells: a review of present methods and the need to identify heterogeneous phenotypes
Hosokawa et al. Size-selective microcavity array for rapid and efficient detection of circulating tumor cells
Zhao et al. An automated high-throughput counting method for screening circulating tumor cells in peripheral blood
Alix-Panabières et al. Technologies for detection of circulating tumor cells: facts and vision
Hyun et al. Isolation and enrichment of circulating biomarkers for cancer screening, detection, and diagnostics
Labib et al. Circulating tumor cell profiling for precision oncology
Boya et al. High throughput, label-free isolation of circulating tumor cell clusters in meshed microwells
Burinaru et al. Detection of circulating tumor cells using microfluidics
Ren et al. Entrapment of prostate cancer circulating tumor cells with a sequential size-based microfluidic chip
Brown et al. Characterization of circulating tumor cells as a reflection of the tumor heterogeneity: myth or reality?
Tadimety et al. Liquid biopsy on chip: a paradigm shift towards the understanding of cancer metastasis
Danova et al. Isolation of rare circulating tumor cells in cancer patients: technical aspects and clinical implications
Nanduri et al. The prognostic role of circulating tumor cells in colorectal cancer
JP2016527907A (en) Selective delivery of substances to cells
Jakabova et al. Molecular characterization and heterogeneity of circulating tumor cells in breast cancer
US20180231555A1 (en) Systems and methods for isolating target particles and their use in diagnostic, prognostic, and therapeutic methods
Yin et al. Detection of circulating tumor cells by fluorescence microspheres-mediated amplification